Orrstown Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,484
Closed -$322K 134
2024
Q4
$322K Sell
3,484
-220
-6% -$19.8K 0.09% 115
2024
Q3
$311K Buy
+3,704
New +$283K 0.09% 114
2018
Q2
Sell
-180
Closed -$14K 321
2018
Q1
$14K Buy
180
+145
+414% +$11.5K 0.02% 211
2017
Q4
$3K Sell
35
-475
-93% -$36.1K ﹤0.01% 272
2017
Q3
$41K Buy
510
+357
+233% +$27.3K 0.05% 154
2017
Q2
$11K Buy
153
+93
+155% +$6.19K 0.01% 219
2017
Q1
$4K Sell
60
-85
-59% -$5.98K ﹤0.01% 238
2016
Q4
$11K Sell
145
-265
-65% -$19.7K 0.01% 183
2016
Q3
$32K Buy
410
+170
+71% +$13.8K 0.03% 149
2016
Q2
$20K Buy
+240
New +$21.3K 0.02% 151

Other funds holding GILD

Orrstown Financial Services's GILD Position: Q1 2025 in Review

Orrstown Financial Services sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 3,484 shares — an estimated $322K sold.

Orrstown Financial Services first reported a position in GILD in Q2 2016 and held it in 10 quarters. The position peaked at $322K in Q4 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Orrstown Financial Services reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Orrstown Financial Services sold 3,484 Gilead Sciences shares in Q1 2025, an estimated $322K.
  • Orrstown Financial Services first reported a position in Gilead Sciences in Q2 2016 and held it in 10 quarters.
  • Orrstown Financial Services's Gilead Sciences position peaked at $322K in Q4 2024.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Orrstown Financial Services's 13F filing for Q1 2025, filed 14 Apr 2025.